Versant Capital Management, Inc Coherus Bio Sciences, Inc. Transaction History

Versant Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	BUY	$3.74 - $5.45 $1,656 - $2,414	443 New	443 $1,000
Q1 2023 Apr 10, 2023	BUY	$5.89 - $10.52 $4,517 - $8,068	767 New	767 $5,000
Q1 2021 Apr 27, 2021	SELL	$14.42 - $21.39 $749 - $1,112	-52 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$16.56 - $18.94 $99 - $113	-6 Reduced 10.34%	52 $0
Q3 2020 Nov 02, 2020	BUY	$17.41 - $19.89 $1,009 - $1,153	58 New	58 $1,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.